Autologous Blood-Derived Extracellular Vesicles (Exosomes) For Nebulized Respiratory-Tract Delivery: From Point-Of-Care Isolation to Upper-Airway and Pulmonary Regenerative Signaling
DOI:
https://doi.org/10.22270/ajprd.v14i5.1873Abstract
Objective: To examine whether an autologous blood-derived extracellular vesicle (EV)/exosome-enriched fraction prepared at the point of care can be coupled to a closed medical nebulizer for delivery to the upper airway and lung, and to define the testing required before such a preparation could be evaluated clinically. Data sources: PubMed-indexed and publisher databases were searched for literature published between 2016 and September 2026 using combinations of terms covering extracellular vesicles, exosomes, serum- and platelet-derived EVs, nebulization, inhalation, aerosol deposition, intranasal delivery, and individual respiratory diseases. Study selection: Preference was given to primary preclinical studies of nebulized or intranasal EV delivery, human nebulized-EV trials, aerosol-science reports, and characterization-standard documents; systematic reviews and meta-analyses were used only as secondary, summarizing evidence. Summary of contents of the article: Fifty-eight sources are synthesized across vesicle biology and nomenclature, the manufacturer-defined kit workflow, nebulizer technologies, preservation of vesicle integrity during aerosolization, regional deposition and cellular uptake, regenerative and immunomodulatory signaling, preclinical evidence in the upper and lower airway, four human nebulized-EV studies, and a pre-/post-nebulization quality-control framework. Conclusion: Nebulization can preserve EV size, cargo, and potency, and locally delivered vesicles act on nasal, airway, and alveolar targets. All human evidence derives from allogeneic, culture-expanded MSC-EV products; no autologous whole-blood-derived fraction has been nebulized into a human airway. The workflow described is a development concept requiring product-specific validation and regulatory authorization.
Downloads
References
Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles. 2024; 13(2):e12404.
Kadota T, Fujita Y, Araya J, Ochiya T, Kuwano K. Extracellular vesicle-mediated cellular crosstalk in lung repair, remodelling and regeneration. European Respiratory Review. 2022; 31(163):210106.
Park KS, Lässer C, Lötvall J. Extracellular vesicles and the lung: from disease pathogenesis to biomarkers and treatments. Physiological Reviews. 2025; 105(3):1733-1821.
McVey MJ, Maishan M, Blokland KEC, Bartlett N, Kuebler WM. Extracellular vesicles in lung health, disease, and therapy. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2019; 316(6):L977-L989.
Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Hosseinpour Feizi MA, Nieuwland R, et al. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins. Cellular and Molecular Life Sciences. 2018; 75(15):2873-2886.
Antich-Rosselló M, Forteza-Genestra MA, Monjo M, Ramis JM. Platelet-Derived Extracellular Vesicles for Regenerative Medicine. International Journal of Molecular Sciences. 2021; 22(16):8580.
Johnson J, Wu YW, Blyth C, Lichtfuss G, Goubran H, Burnouf T. Prospective Therapeutic Applications of Platelet Extracellular Vesicles. Trends in Biotechnology. 2021; 39(6):598-612.
Zhu Z, Sun S, Jiang T, Zhang L, Chen M, Chen S. A double-edged sword of platelet-derived extracellular vesicles in tissues, injury or repair: The current research overview. Tissue and Cell. 2023; 82:102066.
Han Y, Zhu Y, Youngblood HA, Almuntashiri S, Jones TW, Wang X, et al. Nebulization of extracellular vesicles: A promising small RNA delivery approach for lung diseases. Journal of Controlled Release. 2022; 352:556-569.
Xuan W, Wang S, Alarcon-Calderon A, Bagwell MS, Para R, Wang F, et al. Nebulized platelet-derived extracellular vesicles attenuate chronic cigarette smoke-induced murine emphysema. Translational Research. 2024; 269:76-93.
Gonzalez H, McCarthy S, Masterson C, Byrnes D, Sallent I, Horan E, et al. Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model. Stem Cell Research & Therapy. 2023; 14(1):151.
Xu X, Wang Y, Luo X, Gao X, Gu W, Ma Y, et al. A non-invasive strategy for suppressing asthmatic airway inflammation and remodeling: Inhalation of nebulized hypoxic hUCMSC-derived extracellular vesicles. Frontiers in Immunology. 2023; 14:1150971.
Popowski KD, López de Juan Abad B, George A, Silkstone D, Belcher E, Chung J, et al. Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung. Extracellular Vesicle. 2022; 1:100002.
Dinh PUC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nature Communications. 2020; 11(1):1064.
Zhao R, Wang L, Wang T, Xian P, Wang H, Long Q. Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury. Journal of Controlled Release. 2022; 345:214-230.
Zou M, Hua Y, Zhao Y, Shah S, Zuo W. Airway basal stem cell derived extracellular vesicles promote lung repair in chronic obstructive pulmonary disease. Regenerative Therapy. 2026; 31:101068.
Sánchez SV, Otavalo GN, Gazeau F, Silva AKA, Morales JO. Intranasal delivery of extracellular vesicles: A promising new approach for treating neurological and respiratory disorders. Journal of Controlled Release. 2025; 379:489-523.
Xu M, Ren M, Zhang X, Peng W, Li H, Liao W, et al. Mesenchymal stem cell-derived small extracellular vesicles restored nasal barrier function in allergic rhinitis via miR-143-GSK3B in human nasal epithelial cells. Journal of Allergy and Clinical Immunology. 2025; 155(4):1236-1249.e5.
Yang W, Pan Z, Zhang J, Wang L, Lai J, Fan K, et al. Administration Strategy-Dependent Mechanisms and Effects of Human Adipose Tissue Stem Cell Extracellular Vesicles in Mouse Allergic Rhinitis Treatment. Cell Transplantation. 2025; 34:09636897251325673.
Liu W, Ota M, Tabushi M, Takahashi Y, Takakura Y. Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles. Journal of Controlled Release. 2022; 345:433-442.
Lan M, Zhang Y, Chen Y. Solving the Contamination Conundrum Derived from Coisolation of Extracellular Vesicles and Lipoproteins: Approaches for Isolation and Characterization. Small Methods. 2025; 9(11):e01606.
Zhu W, Huang X, Qiu S, Feng L, Wu Y, Shao H. miR-142-5p Encapsulated by Serum-Derived Extracellular Vesicles Protects against Acute Lung Injury in Septic Rats following Remote Ischemic Preconditioning via the PTEN/PI3K/Akt Axis. Journal of Innate Immunity. 2022; 14(5):532-542.
Tan YY, O’Dea KP, Tsiridou DM, Pac Soo A, Koh MW, Beckett F, et al. Circulating Myeloid Cell-derived Extracellular Vesicles as Mediators of Indirect Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 2023; 68(2):140-149.
Fotouhi F, Nokhbedehghan Z, Khajavi M, Taghizadeh-Hesary F, Alizadeh R, Asghari A, et al. Exploring the role of extracellular vesicles in otorhinolaryngology: From diagnostics to therapeutic potential. International Journal of Pharmaceutics. 2026; 692:126634.
Anderson CF, Grimmett ME, Domalewski CJ, Cui H. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomedicine and Nanobiotechnology. 2020; 12(1):e1586.
Resnier P, Mottais A, Sibiril Y, Le Gall T, Montier T. Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways. Current Gene Therapy. 2016; 16(1):34-46.
Newman SP. Fine Particle Fraction: The Good and the Bad. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2022; 35(1):2-10.
Nikander K, von Hollen D, Larhrib H. The size and behavior of the human upper airway during inhalation of aerosols. Expert Opinion on Drug Delivery. 2017; 14(5):621-630.
Zhang D, Lee H, Wang X, Rai A, Groot M, Jin Y. Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses. Molecular Therapy. 2018; 26(9):2119-2130.
Zhang D, Lee H, Zhu Z, Minhas JK, Jin Y. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2017; 312(1):L110-L121.
Zamlus ZI, Azman M, Lokanathan Y, Fauzi MB, Baki MM. Effects of Wharton’s Jelly Mesenchymal Stem Cells and Its-Derived Small Extracellular Vesicles Loaded into Injectable Genipin-Crosslinked Gelatin Hydrogel on Vocal Fold Fibroblast. Polymers. 2025; 17(19):2653.
Mansouri N, Willis GR, Fernandez-Gonzalez A, Reis M, Nassiri S, Mitsialis SA, et al. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. JCI Insight. 2019; 4(21):e128060.
Gao L, Sun Y, Zhang X, Ma D, Xie A, Wang E, et al. Wnt3a-Loaded Extracellular Vesicles Promote Alveolar Epithelial Regeneration after Lung Injury. Advanced Science. 2023; 10(18):e2206606.
Wang J, Huang R, Xu Q, Zheng G, Qiu G, Ge M, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles Alleviate Acute Lung Injury Via Transfer of miR-27a-3p*. Critical Care Medicine. 2020; 48(7):e599-e610.
Liu P, Yang S, Shao X, Li C, Wang Z, Dai H, et al. Mesenchymal Stem Cells-Derived Exosomes Alleviate Acute Lung Injury by Inhibiting Alveolar Macrophage Pyroptosis. Stem Cells Translational Medicine. 2024; 13(4):371-386.
Zhou Y, Li P, Goodwin AJ, Cook JA, Halushka PV, Chang E, et al. Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury. Critical Care. 2019; 23(1):44.
Hu Q, Zhang S, Yang Y, Yao JQ, Tang WF, Lyon CJ, et al. Extracellular vesicles in the pathogenesis and treatment of acute lung injury. Military Medical Research. 2022; 9(1):61.
Wang T, Wu G, Gao P, Zhuang F, Wang Z, Zhou Z, et al. Inhalation of mesenchymal stromal cell-derived extracellular vesicles activates macrophage polarization through the miR-22-3p/NLRP3/IL-1β pathway, ameliorating lung ischemia - reperfusion injury. Stem Cell Research & Therapy. 2026; 17(1):107.
Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, et al. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation. American Journal of Respiratory and Critical Care Medicine. 2018; 197(1):104-116.
Chen S, Gao J, Zhang T. From mesenchymal stem cells to their extracellular vesicles: Progress and prospects for asthma therapy. Asian Journal of Pharmaceutical Sciences. 2024; 19(4):100942.
Lithopoulos MA, Strueby L, O’Reilly M, Zhong S, Möbius MA, Eaton F, et al. Pulmonary and Neurologic Effects of Mesenchymal Stromal Cell Extracellular Vesicles in a Multifactorial Lung Injury Model. American Journal of Respiratory and Critical Care Medicine. 2022; 205(10):1186-1201.
Feng Z, Zhou J, Liu Y, Xia R, Li Q, Yan L, et al. Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by targeting RGS1 mediated calcium signaling-dependent immune response. Cell Death & Differentiation. 2021; 28(7):2238-2256.
Li S, Zhang J, Feng G, Jiang L, Chen Z, Xin W, et al. The Emerging Role of Extracellular Vesicles from Mesenchymal Stem Cells and Macrophages in Pulmonary Fibrosis: Insights into miRNA Delivery. Pharmaceuticals. 2022; 15(10):1276.
Qiu C, Zhao Z, Xu C, Yuan R, Ha Y, Tu Q, et al. Nebulized milk exosomes loaded with siTGF-β1 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability. Journal of Nanobiotechnology. 2024; 22(1):434.
Gao X, Sun C, Yang Y, Li L, Sha S, Cai S, et al. Nebulized delivery of multi-modular stem cell-derived exosomes for the treatment of pulmonary fibrosis. Nanomedicine: Nanotechnology, Biology and Medicine. 2026; 74:102925.
Laitano R, Calzetta L, Motta E, Puxeddu E, Rogliani P. Role of exosomes in exacerbations of asthma and COPD: a systematic review. Frontiers in Molecular Biosciences. 2024; 11:1356328.
Shi MM, Yang QY, Monsel A, Yan JY, Dai CX, Zhao JY, et al. Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles. Journal of Extracellular Vesicles. 2021; 10(10):e12134.
Zhu YG, Shi Mm, Monsel A, Dai Cx, Dong X, Shen H, et al. Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Research & Therapy. 2022; 13(1):220.
Chu M, Wang H, Bian L, Huang J, Wu D, Zhang R, et al. Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia. Stem Cell Reviews and Reports. 2022; 18(6):2152-2163.
Li M, Huang H, Wei X, Li H, Li J, Xie B, et al. Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment. Signal Transduction and Targeted Therapy. 2025; 10(1):179.
Gelibter S, Marostica G, Mandelli A, Siciliani S, Podini P, Finardi A, et al. The impact of storage on extracellular vesicles: A systematic study. Journal of Extracellular Vesicles. 2022; 11(2):e12162.
Ahmadian S, Jafari N, Tamadon A, Ghaffarzadeh A, Rahbarghazi R, Mahdipour M. Different storage and freezing protocols for extracellular vesicles: a systematic review. Stem Cell Research & Therapy. 2024; 15(1):453.
Jansen EM, van der Koog L, Elferink RAB, Rafie K, Nagelkerke A, Gosens R, et al. Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development. Small. 2026; 22(16):e2411096.
Gou J, Zhang L, Wang G, Li Z, Yin Q, Pan Y. Inhalable Exosomes in Respiratory Therapies with the Transformative Potential. International Journal of Nanomedicine. 2025; Volume 20:14219-14252.
Zhang P, Luo T, Song Z, He H, Yang Y, Jiang J, et al. Inhalable extracellular vesicles as cell-free therapeutics for chronic respiratory disease. Frontiers in Bioengineering and Biotechnology. 2026; 14:1811444.
Khalaj K, Figueira RL, Antounians L, Lauriti G, Zani A. Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19?. Journal of Extracellular Vesicles. 2020; 9(1):1795365.
Tieu A, Hu K, Gnyra C, Montroy J, Fergusson DA, Allan DS, et al. Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta-analysis. Journal of Extracellular Vesicles. 2021; 10(12):e12141.
Zhang X, Cheng Z, Zeng M, He Z. The efficacy of extracellular vesicles for acute lung injury in preclinical animal models: a meta-analysis. BMC Pulmonary Medicine. 2024; 24(1):128.
Published
Versions
- 2026-11-16 (2)
- 2026-10-15 (1)
How to Cite
Issue
Section
Copyright (c) 2026 Dr Leroy Rebello, Dr Sreesudha Chepyala, Sahithi Polineni, Thakre Vinod

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.